Description
β2-glycoprotein is a protein that possesses pronounced anticoagulant activity. This test is intended for the quantitative determination of antibodies to β2-glycoprotein (IgG) in blood serum to help in the diagnosis of antiphospholipid syndrome (APS) and/or to assess thrombotic risk in patients with systemic lupus erythematosus (SLE).
Period of execution
Within 8 days. The specified time does not include the day of biomaterial collection
Biomaterial type